These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 391568)

  • 41. Mechanism of action of a 16-membered macrolide. Binding of rosaramicin to the Escherichia coli ribosome and its subunits.
    Siegrist S; Lagouardat J; Moreau N; LeGoffic F
    Eur J Biochem; 1981 Apr; 115(2):323-7. PubMed ID: 6786880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and X-ray crystal structures.
    Pfister P; Hobbie S; Vicens Q; Böttger EC; Westhof E
    Chembiochem; 2003 Oct; 4(10):1078-88. PubMed ID: 14523926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding site of the bridged macrolides in the Escherichia coli ribosome.
    Xiong L; Korkhin Y; Mankin AS
    Antimicrob Agents Chemother; 2005 Jan; 49(1):281-8. PubMed ID: 15616307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetic studies on the interaction between a ribosomal complex active in peptide bond formation and the macrolide antibiotics tylosin and erythromycin.
    Dinos GP; Kalpaxis DL
    Biochemistry; 2000 Sep; 39(38):11621-8. PubMed ID: 10995229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Interaction of substrates and substrate-like inhibitors with the peptidyltransferase center from Escherichia coli ribosomes].
    Kukhanova MK; Burd SB; Viktorova LS; Nechipurenko IuD; Gottikh BP
    Mol Biol (Mosk); 1984; 18(3):691-703. PubMed ID: 6206391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional consequences of binding macrolides to ribosomes.
    Menninger JR
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():23-34. PubMed ID: 3932309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural origins of aminoglycoside specificity for prokaryotic ribosomes.
    Lynch SR; Puglisi JD
    J Mol Biol; 2001 Mar; 306(5):1037-58. PubMed ID: 11237617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In-vitro uptake of gentamicin and tobramycin by rat renal tubules in the presence or absence of Escherichia coli endotoxin.
    Bergeron MG; Lessard C; Turcotte A
    J Antimicrob Chemother; 1986 Sep; 18(3):375-80. PubMed ID: 3533886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for a conformational change in the exit site of the Escherichia coli ribosome upon tRNA binding.
    Lodmell JS; Tapprich WE; Hill WE
    Biochemistry; 1993 Apr; 32(15):4067-72. PubMed ID: 8385994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binding of neomycin-class aminoglycoside antibiotics to mutant ribosomes with alterations in the A site of 16S rRNA.
    Hobbie SN; Pfister P; Bruell C; Sander P; François B; Westhof E; Böttger EC
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1489-96. PubMed ID: 16569869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tobramycin adenylyltransferase: a new aminoglycoside-inactivating enzyme from Staphylococcus epidermidis.
    Santanam P; Kayser FH
    J Infect Dis; 1976 Aug; 134 Suppl():S33-9. PubMed ID: 972283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of labeled initiation factor IF-1 to ribosomal particles and the relationship to the mode of IF-1 action in ribosome dissociation.
    van der Hofstad GA; Buitenhek A; van den Elsen PJ; Voorma HO; Bosch L
    Eur J Biochem; 1978 Aug; 89(1):221-8. PubMed ID: 359328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Minimal RNA constructs that specifically bind aminoglycoside antibiotics with high affinities.
    Hamasaki K; Killian J; Cho J; Rando RR
    Biochemistry; 1998 Jan; 37(2):656-63. PubMed ID: 9425088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fidelity of the eukaryotic codon-anticodon interaction: interference by aminoglycoside antibiotics.
    Eustice DC; Wilhelm JM
    Biochemistry; 1984 Mar; 23(7):1462-7. PubMed ID: 6722101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thermodynamics of an aminoglycoside modifying enzyme with low substrate promiscuity: The aminoglycoside N3 acetyltransferase-VIa.
    Kumar P; Serpersu EH
    Proteins; 2017 Jul; 85(7):1258-1265. PubMed ID: 28316100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The inductive role of ionic binding in the bactericidal and postexposure effects of aminoglycoside antibiotics with implications for dosing.
    Jackson GG; Lolans VT; Daikos GL
    J Infect Dis; 1990 Aug; 162(2):408-13. PubMed ID: 2115554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis, and biological evaluation of BODIPY-erythromycin probes for bacterial ribosomes.
    Li J; Kim IH; Roche ED; Beeman D; Lynch AS; Ding CZ; Ma Z
    Bioorg Med Chem Lett; 2006 Feb; 16(4):794-7. PubMed ID: 16309904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin.
    Poulsen SM; Kofoed C; Vester B
    J Mol Biol; 2000 Dec; 304(3):471-81. PubMed ID: 11090288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of [14C]chloramphenicol binding to Escherichia coli ribosomes by erythromycin derivatives.
    Pestka S; LeMahieu RA
    Antimicrob Agents Chemother; 1974 Jul; 6(1):39-45. PubMed ID: 15828169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Localization of virginiamycin S binding site on bacterial ribosome by fluorescence energy transfer.
    Di Giambattista M; Thielen AP; Maassen JA; Möller W; Cocito C
    Biochemistry; 1986 Jun; 25(12):3540-7. PubMed ID: 3087416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.